Buy Pine Labs; target of Rs 220: Emkay Global Financial

Moneycontrol • 2 days ago

Original source

Key Investment Pillars

  • Pine Labs' reported revenue was 2.4% above consensus, driven by both IAP (+30.9% yoy) and DITP (+20.8% yoy) growth.
  • The company's indirect network effects across its EMI orchestration platform, dominant prepaid issuing leader position, and deep enterprise integration drive its revenue streams.
  • UPI MDR revenue is expected to contribute to EBITDA growth, with management targeting Rs330-340bn in UPI GTV by FY28.
  • Cost and capex investments are stepping up, with a focus on marketing, platform development, and soundbox procurement.

Thesis Validation Checklist

  • Investors should watch for: (1) revenue growth momentum, (2) EBITDA margin expansion, (3) UPI MDR revenue contribution, and (4) soundbox deployment and monetization.
  • Key risks include regulatory oversight, competition, and credit penetration.
  • The stock trades at 16.9x FY28E EV/EBITDA, with a revised target price of Rs220, implying 24.9x FY28E EV/EBITDA and 53.5x PER.